ArticleClinical and experimental nephrology2025
Machine learning using serial changes in proteinuria during initial steroid therapy to predict treatment response and immunosuppressant use in pediatric idiopathic nephrotic syndrome.
Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning prediction of childhood nephrotic syndrome outcomes.Pediatric nephrology (Berlin, Germany) · 2026Observational
- Pediatrics advances in 2024: choices in allergy, cardiology, critical care, endocrinology, gastroenterology, immunology, infectious diseases, neonatology, nephrology, neurology, nutrition, palliative care respiratory tract illnesses, and social media.Italian journal of pediatrics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundEpidemiological studies on idiopathic nephrotic syndrome (INS) in children have identified no definitive factors predicting steroid-resistant nephrotic syndrome (SRNS) or frequent relapsing nephrotic syndrome. Research using machine learning (ML) has been conducted to predict INS prognosis; however, no studies have evaluated serial changes in proteinuria during initial steroid therapy.
methodsINS patient data were collected from 23 medical centers. ML using clinical and laboratory data at first presentation and time-series features generated using serial changes in urine protein to creatinine ratio (UPCR) during initial steroid therapy were performed to predict SRNS and immunosuppressant use in 329 and 190 patients, respectively. ML models were run to calculate the area under the curve (AUC) and to identify variables contributing to predicted outcomes using the backward stepwise method.
resultsIn the SRNS prediction model, UPCR at the final analysis point (i.e., the last sequential day of UPCR input included for model analysis) and several preceding days substantially contributed to the prediction, with UPCR at the final analysis point being the most significant contributor. The immunosuppressant prediction model achieved an AUC ranging from 0.715 to 0.759 and showed that age, serum albumin, serum total cholesterol, and time-series features (approximate entropy, mean UPCR value between the 20th to 80th percentiles, and 70th percentile UPCR value) were significant contributors.
conclusionsOur ML suggested that UPCR at the final analysis point was an important predictor of SRNS. Age, serum albumin, serum total cholesterol and serial changes in proteinuria contributed to immunosuppressant use.
Indexed as
Identifiers
40512323What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.